ABAVP torches CPM leader’s house SNS, JALPAIGURI, 30 JULY: The Akhil Bhartiya Adivasi Vikash Parishad (ABAVP) and CPI-M activists of Jaigaon have allegedly ransacked and torched a CPI-M member's house last night at Jaigaon. A police car was also damaged. Levelling the allegation, the CPI-M member of Jaigaon 1no Gram Panchayat, Mrs Golapi Oroan, a CPI-M member of Number I gram panchayat said that enraged by the changeover of the gram panchayat from the Left Front to the Congress as a result of a no-confidence motion put up by her and a RSP member, the CPI-M and the ABAVP activists had ransacked and torched her house. Recounting the sequence of events, she said that the Left Front had been dislodged from the control of the GP board yesterday in consequence of a confidence vote tabled by a RSP member Mr Rinku Khati and heself on 1 July. “We put up the no-confidence against the GP pradhan Mrs Padma Das for her uninhibited indulgence in corruption and nepotism. The motion was put to vote yesterday and the Left Front board was dislodged. The Congress has formed the board,” she said. “This has exasperated the CPI-M and the ABAVP activists. They have not accepted my challenge to rampant corruption. They have attacked and torched my residence rendering me destitute, “ she added. Informed of the ransacking the Jaigaon police reached the spot. Burt the enraged activists damaged a police vehicle. According to the officer-in-charge, Mr Pradip Sarkar, Mrs Oaraon has filed an FIR. “We are trying to arrest the miscreants,” he said. However, the local leadership of the CPI-M and the ABAVP rubbished the allegation that their activists were involved in yesterday's incidents. INDIAS SWINE TALLY 509 New Delhi, July 30 (IANS) India continues to report fresh swine flu cases with 11 people including six children being detected with the virus Thursday, taking the total number to 509, health officials said here. At least “2,326 people have been tested so far out of which 509 are positive for Influenza A. Of the 509 positive cases, 365 have been discharged,” said an official statement issued here. The new cases were reported from Delhi (4), Pune (3), Kozhikode (2), Cochin (1), and Hyderabad (1). In Delhi, out of the four cases, three people, including two children aged 12, contracted the virus from a person who had the flu. In Pune, all the three cases - all 11-year-olds - got the virus through those who had the flu. The same was reported in Hyderabad where a five-year-old boy contracted the virus. As more swine flu cases continue to pour in, the government announced that two new health facilities, including the All India Institute of Medical Sciences (AIIMS), will also conduct the tests. “We have not stopped the H1N1 testing as yet. Apart from the National Institute of Communicable Diseases, two other institutes including AIIMS have been equipped to carry tests too,” Health Secretary Naresh Dayal said. The other institute is the Patel Chest institute in the capital. Lid off substandard medicine Malaria, TB, typhoid pills fail test despite panel alert | ||||
G.S. MUDUR, TT, New Delhi, July 30: Patients in India continue to be exposed to substandard medicines six years after a government panel had examined the problem and recommended rapid corrective action, a study has revealed. The study by an international research team has found that several samples of medicines used in the treatment of malaria, tuberculosis and other infections failed tests to assess pharmacologically active ingredients of the drugs. Immunologist Amir Attaran at the University of Ottawa, Canada, collaborated with economists and other researchers in India, the US and the UK to analyse 281 drug samples from Delhi and 260 samples from Chennai picked up in July 2008 and March 2009. Overall, 12 per cent of the samples from Delhi and 5 per cent of the samples from Chennai failed one or both of two tests. Despite its small sample size, Attaran said, the study provides a snapshot of reality with serious implications for health. Even a 2 per cent failure rate might mean thousands of patients in India might be buying drugs unlikely to work, he said. They have reported their findings in the journal Public Library of Science One. Substandard drugs have lower concentrations of pharmacological ingredients than what they should actually contain. The results show that little has changed since 2003 when a 10-member panel led by the then head of the Council of Scientific and Industrial Research, R. Mashelkar, had documented that substandard drugs in India made up 8 per cent to 10 per cent of the domestic pharmaceutical market. The panel had suggested corrective steps to be implemented by 2006. Attaran and his colleagues found failure rates ranging from 2 per cent to 17 per cent(see chart). “We used crude tests — the quickest and least expensive — to catch the most obvious problems. Samples that fail these tests should not be used as medicines,” Attaran told The Telegraph. All samples from five of 26 chemists’ shops in Delhi and 16 out 26 shops in Chennai passed tests, but samples from 10 shops in Delhi and 8 in Chennai had 6 per cent to 10 per cent failure rates. Samples from three shops in Delhi had 20 per cent to 30 per cent failure rates. This non-uniform failure patterns across chemist’s shops suggest that the problem of substandard drugs appears to be driven by a small subset of manufacturers or shops thriving in a poorly regulated environment, the researchers said. A member of the panel that had been chaired by Mashelkar said that although the government had initiated action on the panel’s recommendations, the pace of the corrective steps have been disappointing. “The laws are still weak, there is little deterrence, and substandard and fake drugs still pose a serious problem in India,” Vijay Karan, former Delhi police commissioner and panel member, said. An official in the Central Drugs Standard Control Organisation — the agency which regulates medicines in India — said inspections in various states suggested that about seven per cent of drugs in India might be substandard. A drug industry analyst has questioned the new study’s methodology, arguing that it has information gaps and appears intended to create a scare about drugs from India using a small sample size. But he conceded there were reasons for worry. “We don’t know whether identical brands were picked up from the two cities (Delhi and Chennai) and how close they were to expiry dates,” said Chandra Gulhati, editor of theMonthly Index of Medical Specialities, India, a journal of drugs. But potential sources of problems are variations in manufacturing standards, and transportation and storage of medicines, Gulhati said. “Some chemists’ shops might be switching off their refrigerators at night.” |


No comments:
Post a Comment